XTL BIOPHARMACEUTICALS LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.2 ILa | -3.16% |
|
-7.07% | +162.86% |
| Apr. 30 | XTL Biopharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Apr. 29 | Top Premarket Gainers | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| XTL BIOPHARMACEUTICALS LTD. | Other Biotechnology & Medical Research | -3.16% | -7.07% | +162.86% | +104.44% | +33.33% | 14.06M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- XTLB Stock
- Charts XTL Biopharmaceuticals Ltd.
- Comparison Chart
